Cargando…
Identification of a Novel Antibiotic from Myxobacterium Stigmatella Eracta WXNXJ-B and Evaluation of its Antitumor Effects In-vitro
This work was to isolate and identify the bioactive secondary metabolite which was produced by myxobacterium Stigmatella eracta WXNXJ-B, and to evaluate its antitumor and apoptosis-inducing effects. The results showed that one novel compound (molecular formula C(29)H(25)NO(3)) was isolated, purified...
Autores principales: | Wang, Dahong, Yuan, Jiangfeng, Tao, Wenyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978217/ https://www.ncbi.nlm.nih.gov/pubmed/24734069 |
Ejemplares similares
-
The myxocoumarins A and B from Stigmatella aurantiaca strain MYX-030
por: Gulder, Tobias A M, et al.
Publicado: (2013) -
Identification of a solo acylhomoserine lactone synthase from the myxobacterium Archangium gephyra
por: Albataineh, Hanan, et al.
Publicado: (2021) -
Six Heterocyclic Metabolites from the Myxobacterium Labilithrix luteola
por: Mulwa, Lucky S., et al.
Publicado: (2018) -
Characterization of Four Type IV Pilin Homologues in Stigmatella
aurantiaca DSM17044 by Heterologous Expression in Myxococcus xanthus
por: Tan, Zaigao, et al.
Publicado: (2013) -
Complete Genome Sequence of the Corallopyronin A-Producing Myxobacterium Corallococcus coralloides B035
por: Bouhired, Sarah, et al.
Publicado: (2019)